CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
CorEvitas
Summary
Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the country where the participating registry site is located.
Description
The objective of the registry is to create a cohort of adolescent subjects to evaluate the long-term real-world safety and effectiveness of routine clinical care of treatments for severe AA. Data collected through the registry may be used to address a range of research questions and use cases including, but not limited to: better characterizing the natural history of the disease, evaluating the effectiveness and safety of commercially available medications for the treatment of severe AA in adolescents, providing information to support characterization of adolescent growth and development and o…
Eligibility
- Age range
- 12–17 years
- Sex
- All
- Healthy volunteers
- Not specified
Inclusion Criteria: To be eligible to participate in this registry, an individual must meet all the following criteria: 1. Has ever been diagnosed with severe AA by a dermatologist or a qualified dermatology provider. 2. Is 12-17 years of age at the time of enrollment. 3. Is willing to provide consent/assent for participation in the registry. 4. Has been prescribed a new commercially available advanced therapy and/or conventional systemic therapy for the treatment of severe AA in adolescents in the context of routine clinical care that is consistent with local prescribing guidelines and/or r…
Location
- CorEvitas, LLCWaltham, Massachusetts